Home › Gilead Buys Shortcut For FDA Drug Review For $125 Million
 

Keywords :   


Gilead Buys Shortcut For FDA Drug Review For $125 Million

2014-11-20 19:13:00| Biotech - Topix.net

How much is a fast track for the Food and Drug Administration review of a new drug worth? Try $125 million. In an auction, Gilead Sciences, a maker of HIV and hepatitis medicines, just bought a coupon good for the accelerated review of a drug of the company's choice from Knight Therapeutics, a Canadian company.

Tags: review million drug buys

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
08.11Nissan to lay off thousands of workers as sales drop
08.11Hurricane Rafael Graphics
08.11Hurricane Rafael Wind Speed Probabilities Number 18
08.11Hurricane Rafael Forecast Discussion Number 18
08.11Hurricane Rafael Forecast Advisory Number 18
08.11Hurricane Rafael Public Advisory Number 18
08.11Summary for Hurricane Rafael (AT3/AL182024)
08.11Up close with the 300 tonne driverless trucks
More »